| 1 | 6ICJ |
Peroxisome proliferator-activated receptor gamma | Homo sapiens |
P37231 (PPARG_HUMAN) |
2-butyl-5-[(3-tert-butyl-1,2,4-oxadiazol-5-yl)methyl]-6-methyl-3-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl}pyrimidin-4(3H)-one |
A0L |
 |
SHOW |
| 2 | 3ZU0 |
NAD 5'-nucleotidase | Haemophilus influenzae |
P44569 (5NTD_HAEIN) |
PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER |
A12 |
 |
SHOW |
| 3 | 6HH3 |
ADP-ribose glycohydrolase ARH3 | Latimeria chalumnae |
H3BCW1 (ADPRS_LATCH) |
5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-DIHYDROXYPYRROLIDIN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]ADENOSINE |
A1R |
 |
SHOW |
| 4 | 4B80 |
Acetylcholinesterase | Mus musculus |
P21836 (ACES_MOUSE) |
N-[2-(diethylamino)ethyl]-1-(4-fluorophenyl)methanesulfonamide |
A36 |
 |
SHOW |
| 5 | 6HH5 |
ADP-ribose glycohydrolase ARH3 | Latimeria chalumnae |
H3BCW1 (ADPRS_LATCH) |
Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol |
A3R |
 |
SHOW |
| 6 | 6AKX |
C-C chemokine receptor type 5 | Homo sapiens |
P51681 (CCR5_HUMAN) |
N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-2-yl)propyl]cyclopentanecarboxamide |
A4R |
 |
SHOW |
| 7 | 6AKY |
C-C chemokine receptor type 5 | Homo sapiens |
P51681 (CCR5_HUMAN) |
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-3-yl)propyl]cyclohexane-1-carboxamide |
A4X |
 |
SHOW |
| 8 | 5ORP |
Aurora kinase A | Homo sapiens |
O14965 (AURKA_HUMAN) |
1-[3-chloranyl-5-(trifluoromethyl)pyridin-2-yl]-1,4-diazepane |
A5K |
 |
SHOW |
| 9 | 6PZU |
Histone deacetylase 6 | Danio rerio |
F8W4B7 (F8W4B7_DANRE) |
N-[(benzyloxy)carbonyl]-L-leucyl-N-{[4-(hydroxycarbamoyl)phenyl]methyl}-L-alaninamide |
A6I |
 |
SHOW |
| 10 | 4A7I |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [2-(1--ISOPROPYL-PIPERIDIN-4-YLSULFAMOYL)-ETHYL]-AMIDE |
A7I |
 |
SHOW |
| 11 | 1UT6 |
Acetylcholinesterase | Tetronarce californica |
P04058 (ACES_TETCF) |
N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE |
A8N |
 |
SHOW |
| 12 | 2RCW |
Poly [ADP-ribose] polymerase 1 | Homo sapiens |
P09874 (PARP1_HUMAN) |
trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium |
AAI |
 |
SHOW |
| 13 | 2PK4 |
Plasminogen | Homo sapiens |
P00747 (PLMN_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
 |
SHOW |
| 14 | 6DCM |
Tissue-type plasminogen activator | Homo sapiens |
P00750 (TPA_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
SHOW |
| 15 | 1CEA |
Plasminogen | Homo sapiens |
P00747 (PLMN_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
SHOW |
| 16 | 1PK2 |
Tissue-type plasminogen activator | Homo sapiens |
P00750 (TPA_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
SHOW |
| 17 | 3RQW |
Gamma-aminobutyric-acid receptor subunit beta-1 | Dickeya dadantii |
E0SJQ4 (E0SJQ4_DICD3) |
ACETYLCHOLINE |
ACH |
 |
SHOW |
| 18 | 3WIP |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
ACETYLCHOLINE |
ACH |
|
SHOW |
| 19 | 2RIN |
Putative choline ABC transporter, periplasmic solute-binding component | Rhizobium meliloti |
Q92N37 (Q92N37_RHIME) |
ACETYLCHOLINE |
ACH |
|
SHOW |
| 20 | 2XZ5 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
ACETYLCHOLINE |
ACH |
|
SHOW |
| 21 | 2ACE |
Acetylcholinesterase | Tetronarce californica |
P04058 (ACES_TETCF) |
ACETYLCHOLINE |
ACH |
|
SHOW |
| 22 | 1S9E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE |
ADB |
 |
SHOW |
| 23 | 5U7W |
Apyrase | Trifolium repens |
B9U139 (B9U139_TRIRP) |
ADENINE |
ADE |
 |
SHOW |
| 24 | 2B8J |
Class B acid phosphatase | Escherichia coli |
P0AE22 (APHA_ECOLI) |
ADENOSINE |
ADN |
 |
SHOW |
| 25 | 4H2G |
5'-nucleotidase | Homo sapiens |
P21589 (5NTD_HUMAN) |
ADENOSINE |
ADN |
|
SHOW |